Table 2.
Summary of ACIP Recommendations for pneumococcal vaccines in adult patients with an immunocompromising condition such as rheumatoid arthritisa
| Prior PPSV-23 Vaccination | Recommendation |
|---|---|
| None | -Give PCV-13 followed by PPSV-23 (at least 8 weeks later) |
| -5 years later, give a booster PPSV-23 | |
| One prior PPSV-23 | -Give PCV-13 (>1 year from PPSV-23) |
| -Give booster PPSV-23 (5 years after the last PPSV-23) | |
| Two prior doses of PPSV-23 | -If >1 year from last PPSV-23, then give PCV-13 |
| -Patients who are under age 65 are eligible to receive one further PPSV-23 after turning 65 years old. |
a
Adapted from the CDC. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)